1,721,032 research outputs found
Two cases of successful Immune Tolerance Induction Rescue (ITI-R) with simoctocog alfa (rhFVIII) in hemophilia A patients and high-titer inhibitors.
No full textConditions associated with infections of indwelling central venous catheters in cancer patients: a summary
No full text
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
A practical approach to diagnosis and treatment of symptomatic thromboembolic events in children with Acute Lymphoblastic Leukemia:recommendations of the "Coagulation Defects"AIEOP Working Group
No full textCurrent management of the hemophilic child: a demanding interlocutor. Quality of life and adequate cost-efficacy analysis.
No full textHemophilias are the most known inherited bleeding disorders. The challenges in the management of hemophilic children are different from those in adults: prophylaxis regimen removed the hallmark of crippling disease with lifelong disabilities; individualized regimens are being implemented in order to overcome venous access problems. Presently, at least in high-income countries, advances in treatment of hemophilia resulted in continuous improvement of the patients' quality of life and life expectancy. Inhibitors remain the most severe complication of hemophilia therapy. The treatment' compliance is the key to achieve a successful management. The patient, his family, the medical and psychological team are the players of a comprehensive care system. The current management of hemophilic children is the example of huge resource investments enabling long-term benefits in particular quality of life as a primary objective of the healthcare process
Evidence for a 1980 HTLV-III infection in a currently asymptomatic B haemophiliac in Italy
No full textChanging pattern of pathogens causing broviac catheter related bactaeremias in children with cancer
No full textvon Willebrand factor multimer composition is modified following oral Methionine load in women with thrombosis, but not in healthy women.
No full textHealth economic models in hemophilia A and utility assumptions from a clinician's perspective
No full text- …
